- Stocks
- Healthcare
- NASDAQ: PODD

Price (delayed)

$278.7

Market cap

$18.47B

P/E Ratio

1,990.71

Dividend/share

N/A

EPS

$0.14

Enterprise value

$18.72B

PODD's net income has surged by 75% year-on-year and by 31% since the previous quarter

The EPS has soared by 75% YoY and by 27% from the previous quarter

PODD's price to earnings (P/E) is 47% higher than its last 4 quarters average of 1351.8

The company's debt rose by 19% YoY

What are the main financial stats of PODD

Market
Valuations
Earnings

Shares outstanding

66.27M

Market cap

$18.47B

Enterprise value

$18.72B

Price to earnings (P/E)

1,990.71

Price to book (P/B)

31.47

Price to sales (P/S)

19.22

EV/EBIT

306.83

EV/EBITDA

155.58

EV/Sales

19.52

Revenue

$958.7M

EBIT

$61M

EBITDA

$120.3M

Free cash flow

-$82.5M

Per share
Balance sheet
Liquidity

EPS

$0.14

Free cash flow per share

-$1.25

Book value per share

$8.86

Revenue per share

$14.5

TBVPS

$26.78

Total assets

$1.84B

Total liabilities

$1.25B

Debt

$1.07B

Equity

$585.3M

Working capital

$1.01B

Debt to equity

1.82

Current ratio

6.42

Quick ratio

5.11

Net debt/EBITDA

2.05

Margins
Efficiency
Dividend

EBITDA margin

12.5%

Gross margin

65%

Net margin

0.9%

Operating margin

6.3%

Return on assets

0.5%

Return on equity

1.5%

Return on invested capital

3.6%

Return on capital employed

3.7%

Return on sales

6.4%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Insulet stock price performed over time

Intraday

-0.35%

1 week

5.7%

1 month

-0.94%

1 year

37.05%

YTD

9.02%

QTD

1.53%

How have Insulet's revenue and profit performed over time

Revenue

$958.7M

Gross profit

$622.9M

Operating income

$60.3M

Net income

$8.9M

Gross margin

65%

Net margin

0.9%

PODD's net income has surged by 75% year-on-year and by 31% since the previous quarter

The company's net margin rose by 29% YoY and by 13% QoQ

PODD's gross profit is up by 24% YoY and by 7% from the previous quarter

PODD's revenue is up by 23% year-on-year and by 6% since the previous quarter

What is Insulet's growth rate over time

What is Insulet stock price valuation

P/E

1,990.71

P/B

31.47

P/S

19.22

EV/EBIT

306.83

EV/EBITDA

155.58

EV/Sales

19.52

The EPS has soared by 75% YoY and by 27% from the previous quarter

PODD's price to earnings (P/E) is 47% higher than its last 4 quarters average of 1351.8

PODD's price to book (P/B) is 32% less than its 5-year quarterly average of 46.1 but 20% more than its last 4 quarters average of 26.3

The equity is down by 3% QoQ

PODD's price to sales (P/S) is 70% higher than its 5-year quarterly average of 11.3 and 11% higher than its last 4 quarters average of 17.3

PODD's revenue is up by 23% year-on-year and by 6% since the previous quarter

How efficient is Insulet business performance

PODD's ROE has shrunk by 61% YoY

Insulet's return on invested capital has increased by 38% YoY and by 6% QoQ

The return on assets has increased by 25% since the previous quarter

The ROS has grown by 23% YoY and by 4.9% from the previous quarter

What is PODD's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for PODD.

How did Insulet financials performed over time

The total assets is 47% higher than the total liabilities

The total assets has soared by 66% YoY

Insulet's quick ratio has soared by 66% YoY and by 3% from the previous quarter

The company's debt is 82% higher than its equity

The debt to equity has plunged by 88% YoY but it has increased by 4% from the previous quarter

The company's debt rose by 19% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.